Preliminary study of a challenge test to the patients with Japanese cedar pollinosis using an environmental exposure unit

Auris Nasus Larynx

Volumn 37, Issue 6, 2010, Pages 694-699

  Ito, Kanako ^a   Terada, Tetsuya ^a   Yuki, Ayumi ^a   Ichihara, Takahiro ^a   Hyo, Sawako ^a   Kawata, Ryo ^a   Takenaka, Hiroshi ^a   Amano, Kentaro ^b   Ishiguro, Takeshi ^b   Ro, Toshitami ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b TAKENAKA CORPORATION   (Japan)

Author keywords

Allergen challenge chamber; Allergic rhinitis; Allergy symptom; Japanese cedar pollen

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; JAPANESE CEDAR; MALE; POLLEN ALLERGY; PROVOCATION TEST; QUANTITATIVE ANALYSIS; VOLUNTEER;

CRYPTOMERIA; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; IMMUNOLOGIC TESTS; MALE; NASAL OBSTRUCTION; PRURITUS; RHINITIS, ALLERGIC, SEASONAL; SEASONS; SNEEZING; TIME FACTORS; YOUNG ADULT;

EID: 77955508757     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2010.04.001     Document Type: Article

References (16)

1. Kaneko Y., Motohashi Y., Nakamura H., Endo T., Eboshida A. Increasing prevalence of Japanese cedar pollinosis: a meta-regression analysis. Int Arch Allergy Immunol 2005, 136(April (4)):365-371. [Epub 2005 March 2].
2. Stuck B.A., Czajkowski J., Hagner A.E., Klimek L., Verse T., Hörmann K., et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004, 113(April (4)):663-668.
3. Settipane R.A. Complications of allergic rhinitis. Allergy Asthma Proc 1999, 20(July-August (4)):209-213. Review.
4. Thompson A.K., Juniper E., Meltzer E.O. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000, 85(November (5)):338-347. quiz 347-8.
5. Schoenwetter W.F., Dupclay L., Appajosyula S., Botteman M.F., Pashos C.L. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 2004, 20(March (3)):305-317.
6. Hyo S., Fujieda S., Kawada R., Kitazawa S., Takenaka H. The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen. Ann Allergy Asthma Immunol 2005, 94(April (4)):457-464.
7. Bronsky E.A., Aaronson D.W., Berkowitz R.B., Chervinsky P., Graft D., Kaiser H.B., et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997, 79(July (1)):51-56.
8. Horak F., Stübner P., Zieglmayer R., Kavina A., De Vos C., Burtin B., et al. Controlled comparison of the efficacy and safety of cetirizine 10mg o.d. and fexofenadine 120mg o.d. in reducing symptoms of seasonal allergic rhinitis. Int Arch Allergy Immunol 2001, 125(May (1)):73-79.
9. Day J.H., Briscoe M.P., Welsh A., Smith J.N., Clark A., Ellis A.K., et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol 1997, 79(December (6)):533-540.
10. Krug N., Hohlfeld J.M., Geldmacher H., Larbig M., Heermann R., Lavallee N., et al. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. Allergy 2005, 60(March (3)):354-359.
11. Horak F., Jäger S. The Vienna challenge chamber (VCC)-a new method for allergen exposition test. Wien Klin Wochenschr 1987, 99:509-510.
12. Horak F., Jäger S. VCC-Vienna challenge chamber-the protective effects of Astemizole. Allergy 1988, 43(Suppl. 7):110.
13. Day J.H., Briscoe M.P. Environmental exposure unit: a system to test anti-allergic treatment. Ann Allergy Asthma Immunol 1999, 83(August (2)):83-89. quiz 89-93 [Review].
14. Connell J.T. Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. J Allergy 1969, 43(January (1)):33-44. [no abstract available].
15. Nielsen L., Johnsen C.R., Bindslev-Jensen C., Poulsen L.K. Efficacy of acrivastine in the treatment of allergic rhinitis during natural pollen exposure: onset of action. Allergy 1994, 49(September (8)):630-636.
16. Day J.H., Ellis A.K., Rafeiro E., Ratz J.D., Briscoe M.P. Experimental models for the evaluation of treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2006, 96(February (2)):263-277. quiz 277-8, 315. Review.